Vilobelimab (Anti-Complement C5)
Vilobelimab (Anti-Complement C5) is a monoclonal antibody targeting C5a, a pro-inflammatory complement division product that plays a central role in mediating organ dysfunction. It may be used in studies related to sepsis, COVID-19, etc. MW :145.9 KD.
| Supplier | Selleck Chemicals |
|---|---|
| Product # | A3101 |
| Sku # | A3101-1mg*25 |
| Pricing | 1mg*25, $5070.00 |